Understanding the H5N1 Threat
February 3, 2025
With new cases of avian influenza appearing, what does this mean for global health and what are drug developers doing about it?
4 min read
This issue celebrates the Company of the Year Awards 2025! We reveal the best CDMO, top bioprocessing equipment supplier, and more. The issue also covers managing change in devices for patients, developing pediatric liquid formulations, and navigating the complexities of ADCs. Experts from across the industry give theirs views on AI and automation, and we sit down to interview Lars Petersen, President and CEO of FUJIFILM Diosynth Biotechnologies.
February 3, 2025
With new cases of avian influenza appearing, what does this mean for global health and what are drug developers doing about it?
4 min read
November 7, 2024
Developing science is good; developing successful commercialization strategies is great.
October 2, 2024
Sitting Down With… Lars Petersen, President and CEO, FUJIFILM Diosynth Biotechnologies
5 min read
September 19, 2024
Regulators want more pediatric formulations. Companies often turn to liquids, but there are specific challenges that need to be considered.
4 min read
August 1, 2024
ADC development is a complex process that can be streamlined – and optimized – by taking the right partnerships and strategies into consideration.
5 min read
June 21, 2024
We need to step away from assumptions on device interchangeability and find out what patients really want
4 min read
False
False